Keratoacanthomas and spitz tumors: Are they both 'self-limiting' variants of malignant cutaneous neoplasms?

Dermatology

Volumn 219, Issue 1, 2009, Pages 3-6

  Zalaudek, Iris ^a   Bonifazi, Ernesto ^b   Ferrara, Gerardo ^c   Argenziano, Giuseppe ^d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF BARI   (Italy)

^c G RUMMO HOSPITAL   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; K RAS PROTEIN; RAS PROTEIN;

CANCER CONTROL; CLINICAL ASSESSMENT; DISEASE COURSE; EDITORIAL; EPILUMINESCENCE MICROSCOPY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC RISK; HISTOPATHOLOGY; HUMAN; JUVENILE MELANOMA; KERATOACANTHOMA; LYMPH NODE METASTASIS; METASTASIS; MORPHOLOGY; MORTALITY; ONCOGENE N RAS; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

GENES, RAS; HUMANS; KERATOACANTHOMA; LYMPHATIC METASTASIS; NEVUS, EPITHELIOID AND SPINDLE CELL; SKIN NEOPLASMS;

EID: 67651085387     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213759     Document Type: Editorial

References (26)

1. Schwartz RA: Keratoacanthoma: a clinicopathologic enigma. Dermatol Surg 2004;30:326-333.
2. de Lima Vazquez V, Sachetto T, Perpetuo NM, Carvalho AL: Prognostic factors for lymph node metastasis from advanced squamous cell carcinoma of the skin of the trunk and extremities. World J Surg Oncol 2008;6:73. (Pubitemid 352044779)
3. Barnhill RL: The spitzoid lesion: rethinking Spitz tumors, atypical variants, 'spitzoid melanoma' and risk assessment. Mod Pathol 2006;19(suppl 2):S21-S33. (Pubitemid 43172307)
4. Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC Jr, Rabkin MS, Ronan SG, White WL, Piepkorn M: Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999;30:513-520. (Pubitemid 29218042)
5. Ferrara G, Argenziano G, Soyer HP, Chimenti S, Di Blasi A, Pellacani G, Peris K, Piccolo D, Rubegni P, Seidenari S, Staibano S, Zalaudek I, De Rosa G: The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol 2005;141:1381-1387. (Pubitemid 41668691)
6. Argenziano G, Scalvenzi M, Staibano S, Brunetti B, Piccolo D, Delfino M, De Rosa G, Soyer HP: Dermatoscopic pitfalls in differentiating pigmented Spitz naevi from cutaneous melanomas. Br J Dermatol 1999;141:788-793.
7. Pizzichetta MA, Argenziano G, Grandi G, de Giacomi C, Trevisan G, Soyer HP: Morphologic changes of a pigmented Spitz nevus assessed by dermoscopy. J Am Acad Dermatol 2002;47:137-139.
8. Argenziano G, Zalaudek I, Ferrara G, Lorenzoni A, Soyer HP: Involution: the natural evolution of pigmented Spitz and Reed nevi? Arch Dermatol 2007;143:549-551.
9. Liu W, Dowling JP, Murray WK, McArthur GA, Thompson JF, Wolfe R, Kelly JW: Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006;142:1551-1558. (Pubitemid 44969210)
10. Nino M, Brunetti B, Delfino S, Brunetti B, Panariello L, Russo D: Spitz nevus: follow-up study of 8 cases of childhood starburst type and proposal for management. Dermatology 2009;218:48-51.
11. Bonifazi E, Ciampo L, Milano A, Argenziano G: Pediatric dermatology: hypopigmented Spitz nevus in children. Eur J Pediatr Dermatol 2007;16:33-48.
12. Florell SR, Bowen AR, Hanks AN, Murphy KJ, Grossman D: Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi. J Cutan Pathol 2005;32:45-49. (Pubitemid 40174105)
13. Schmoeckel C, Wildi G, Schäfer T: Spitz nevus versus malignant melanoma: Spitz nevi predominate on the thighs in patients younger than 40 years of age, melanomas on the trunk in patients 40 years of age or older. J Am Acad Dermatol 2007;56:753-758. (Pubitemid 46561009)
14. Ansai S, Manabe M: Possible spontaneous regression of a metastatic lesion of keratoacanthoma-like squamous cell carcinoma in a regional lymph node. J Dermatol 2005;32:899-903. (Pubitemid 43002073)
15. Busam KJ, Pulitzer M: Sentinel lymph node biopsy for patients with diagnostically controversial spitzoid melanocytic tumors? Adv Anat Pathol 2008;15:253-262.
16. van Dijk MC, Bernsen MR, Ruiter DJ: Analysis of mutations in B-RAF, N-RAS, and HRAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol 2005;29:1145-1151.
17. Nagasaka T, Lai R, Medeiros LJ, Brynes RK, McCourty A, Harada T, Saddik M: Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study. Am J Dermatopathol 1999;21:115-120. (Pubitemid 29162868)
18. Bastian BC, LeBoit PE, Pinkel D: Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000;157:967-972.
19. Gill M, Celebi JT: B-RAF and melanocytic neoplasia. J Am Acad Dermatol 2005;53:108-114.
20. Gill M, Renwick N, Silvers DN, Celebi JT: Lack of BRAF mutations in Spitz nevi. J Invest Dermatol 2004;122:1325-1326. (Pubitemid 38651110)
21. Maldonado JL, Timmerman L, Fridlyand J, Bastian BC: Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol 2004;164:1783-1787. (Pubitemid 38529780)
22. Corominas M, Leon J, Kamino H, Cruz-Alvarez M, Novick SC, Pellicer A: Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Oncogene 1991;6:645-651. (Pubitemid 21924131)
23. Matesanz F, Oliva MR, Villamarin A, Kamino H, Pellicer A: Differential expression of the H-ras mutated and normal alleles in rabbit DMBA-induced keratoacanthomas. Int J Cancer 1995;61:679-682.
24. Leon J, Kamino H, Steinberg JJ, Pellicer A: H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system. Mol Cell Biol 1988;8:786-793. (Pubitemid 18044884)
25. Burnworth B, Arendt S, Muffler S, Steinkraus V, Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P: The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Eur J Cell Biol 2007;86:763-780. (Pubitemid 350082194)
26. Burnworth B, Popp S, Stark HJ, Steinkraus V, Bröcker EB, Hartschuh W, Birek C, Boukamp P: Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 2006;25:4399-4412. (Pubitemid 44141628)